The UK CMA welcomes the EU Court of Justice ruling in a pay-for-delay case (Paroxetine Case)

CMA welcomes EU Court ruling in pay-for-delay drug case* The CMA welcomes a ruling from the EU Court of Justice in relation to its case that drug companies supplying an antidepressant called paroxetine broke the law. The ruling, released today, follows appeals from GlaxoSmithKline and other pharmaceutical companies against the Competition and Markets

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

UK Competition Authority, The UK CMA welcomes the EU Court of Justice ruling in a pay-for-delay case (Paroxetine Case), 30 January 2020, e-Competitions January 2020, Art. N° 93150

Visites 420

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues